Search research articles
Contact Us
Filters
Showing results (81-90 of 226) with videos related to
Page
of 23
Sort By:
Pharmacogenetics and Genomics
|
January 12, 2024
Common dihydropyrimidinase ( DPYS ) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort
Samantha J Medwid, Jaymie L Mailloux, Theodore J Wigle, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2007
Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity
Elaine M Leslie, Paul B Watkins, Richard B Kim, et al.
American Journal of Hypertension
|
October 31, 2006
Inability to upregulate cytochrome P450 4A and 2C causes salt sensitivity in young Sprague-Dawley rats
Sowndramalingam Sankaralingam, Kaushik M Desai, Hartmut Glaeser, et al.
Inflammatory Bowel Diseases
|
May 8, 2024
Infliximab Tissue Concentrations in Patients With Stable Ulcerative Colitis Are Correlated With More Durable Infliximab-associated Disease Remission
John Choi, Qian Wang, Melanie Beaton, et al.
Current Oncology (Toronto, Ont.)
|
January 20, 2023
<i>DPYD</i> Exon 4 Deletion Associated with Fluoropyrimidine Toxicity and Importance of Copy Number Variation
Theodore J Wigle, Samantha Medwid, Cameron Ross, et al.
BMC Gastroenterology
|
February 19, 2021
High infliximab trough concentrations are associated with sustained histologic remission in inflammatory bowel disease: a prospective cohort study
Aze Wilson, Bethany Choi, Michael Sey, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
September 30, 2016
Genetic Determinants of Clozapine-Induced Metabolic Side Effects
Kamini Vasudev, Yun-Hee Choi, Ross Norman, et al.
Molecular Pharmaceutics
|
April 30, 2009
Identification, expression, and functional characterization of full-length and splice variants of murine organic anion transporting polypeptide 1b2
Henriette E Meyer Zu Schwabedissen, Joseph A Ware, Rommel G Tirona, et al.
Journal of the Canadian Association of Gastroenterology
|
June 6, 2024
Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease
Cheng-Chun Tai, Samantha Medwid, Keith Mclntosh, et al.
The Journal of Biological Chemistry
|
December 9, 2003
Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition
Richard H Ho, Brenda F Leake, Richard L Roberts, et al.
Page
of 23
Search research articles
Search
Showing results (81-90 of 226) with videos related to
Sort By:
Page
of 23
Pharmacogenetics and Genomics
|
January 12, 2024
Common dihydropyrimidinase ( DPYS ) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort
Samantha J Medwid, Jaymie L Mailloux, Theodore J Wigle, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2007
Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity
Elaine M Leslie, Paul B Watkins, Richard B Kim, et al.
American Journal of Hypertension
|
October 31, 2006
Inability to upregulate cytochrome P450 4A and 2C causes salt sensitivity in young Sprague-Dawley rats
Sowndramalingam Sankaralingam, Kaushik M Desai, Hartmut Glaeser, et al.
Inflammatory Bowel Diseases
|
May 8, 2024
Infliximab Tissue Concentrations in Patients With Stable Ulcerative Colitis Are Correlated With More Durable Infliximab-associated Disease Remission
John Choi, Qian Wang, Melanie Beaton, et al.
Current Oncology (Toronto, Ont.)
|
January 20, 2023
<i>DPYD</i> Exon 4 Deletion Associated with Fluoropyrimidine Toxicity and Importance of Copy Number Variation
Theodore J Wigle, Samantha Medwid, Cameron Ross, et al.
BMC Gastroenterology
|
February 19, 2021
High infliximab trough concentrations are associated with sustained histologic remission in inflammatory bowel disease: a prospective cohort study
Aze Wilson, Bethany Choi, Michael Sey, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
September 30, 2016
Genetic Determinants of Clozapine-Induced Metabolic Side Effects
Kamini Vasudev, Yun-Hee Choi, Ross Norman, et al.
Molecular Pharmaceutics
|
April 30, 2009
Identification, expression, and functional characterization of full-length and splice variants of murine organic anion transporting polypeptide 1b2
Henriette E Meyer Zu Schwabedissen, Joseph A Ware, Rommel G Tirona, et al.
Journal of the Canadian Association of Gastroenterology
|
June 6, 2024
Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease
Cheng-Chun Tai, Samantha Medwid, Keith Mclntosh, et al.
The Journal of Biological Chemistry
|
December 9, 2003
Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition
Richard H Ho, Brenda F Leake, Richard L Roberts, et al.
Page
of 23